Filter your results
- 3
- 3
- 3
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsScience, 2018, 359 (6371), pp.91-97. ⟨10.1126/science.aan3706⟩
Journal articles
hal-02126484v1
|
|||
|
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeCell Research, 2019, 29 (10), pp.846-861. ⟨10.1038/s41422-019-0224-x⟩
Journal articles
hal-02461559v1
|
||
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in miceJournal of Hepatology, 2017, 66 (4), pp.682-684. ⟨10.1016/j.jhep.2016.11.008⟩
Journal articles
hal-01608470v1
|